Scrip 100
The latest Scrip 100 ranking is now available and includes data on R&D spending, total revenues, employee numbers and sales for the top 100 biopharmaceutical companies (based on FY 2024).
• By
AstraZeneca, Lilly, Novo Nordisk and Amgen all moved up in the rankings on the Scrip 100 leaderboard powered by impressive double-digit growth.